Abstract
Mixtures containing equal masses of poly(I) and copolymers containing poly(5-hydroxycytidylic acid) [poly(ho5C) copolymers] protect mice against encephalomyocarditis (e.m.c.) virus infection and the protective effect is greatest 6 h before infection. The batches of poly(ho5C) copolymer used in these studies were obtained by Br water treatment of poly(C) and contained cytidine, bromocytidine and hydroxycytidine residues with the latter component comprising 50-81% of the total residues in different preparations. These copolymers were used in solution or in a gelled form obtained by freezing in the absence of salt. Evidence is presented which shows that double stranded complexes do not form when the poly(ho5C) copolymers are mixed with poly(I). Protection of mice with mixtures of poly(I) and poly(ho5C) copolymer was slightly greater than was previously observed with sequential administration of poly(I) followed by poly(C) or the homopolymer form of poly(ho5C). The gelled form of poly(ho5C) copolymer conferred slightly greater protection than soluble poly(ho5C) copolymer. The percentage of hydroxycytidine residues in the copolymers did not affect the degree of protection conferred by mixtures of the copolymers with poly(I). Administration of mixtures of poly(I) and soluble poly(ho5C) copolymer i.p. was more effective than i.v. when high doses were used at 6 h before infection. At this time, 200 .mu.g/mouse of a mixture of poly(I) and poly(ho5C) copolymer was as protective as 60 .mu.g/mouse poly(I:C) but the toxicity of mixtures of poly(I) and poly(ho5C) was less than 1/10 that of poly(I:C). The mechanism of the protective effect with single stranded polynucleotides cannot yet be stated. However, the protection by mixtures of poly(I) and poly(ho5C) copolymer does not seem to be through interferon production. Serum from mice treated with the mixture of polynucleotides cannot confer protection on other mice subsequently exposed to infection. The mixtures do not hypo-reactivate the protective effect of poly(I:C) treatment which would be expected if both effects had a common basis in the interferon phenomenon. Treatment with the mixture does not result in a stimulation of immune response produced by e.m.c. virus infection.